Door Open For Zelnorm Return Despite Marketing “Suspension,” Novartis Says

Novartis is emphasizing that the removal of Zelnorm from the market is a suspension rather than a withdrawal

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet